Purchase Order 75N91018P00359

Genewiz, LLC, a subsidiary of Azenta, Inc., was awarded a $4,997.50 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute for sequencing reactions services. The contract, issued on November 2, 2015, with an ultimate completion date of September 30, 2017, was performed at Genewiz's facility in South Plainfield, New Jersey. No set-aside designation was used for this award. This BPA call represents a task order for genomic sequencing services that aligns...

<p>The National Cancer Institute issued a purchase order to Genewiz, LLC for whole exome sequencing of formalin-fixed paraffin-embedded prostate cancer biopsies, valued at $63,280.00, awarded August 1, 2018. Performance runs from August 1, 2018 through September 1, 2018 at the vendor's facility in South Plainfield, New Jersey. The order carries firm fixed-price pricing and no set-aside designation.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Genewiz, LLC for $20,689.70, effective June 27, 2019, with completion by July 26, 2019. The order is firm fixed price with no set-aside. Work is performed at Genewiz's facility in South Plainfield, New Jersey. Genewiz provides genomic services including gene synthesis, next-generation sequencing, Sanger sequencing, and bioinformatics analysis to support federal life sciences research initiatives.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for sequencing services valued at $12,068.21, with an award date of September 12, 2019 and completion date of October 12, 2019. Work is performed in Piscataway, New Jersey. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $11,484.18 on August 12, 2019, for sequencing services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price and is scheduled for completion by September 11, 2019.</p>

Genewiz, LLC, a global contract research organization specializing in genomic services, was awarded a firm fixed price purchase order valued at $5,390.00 by the Plains Area civilian federal agency for whole genome genetic sequencing services. The contract, issued on April 19, 2017, with an ultimate completion date of June 19, 2017, represents a focused engagement for Genewiz's core competency in next-generation sequencing and genomic analysis. The work is to be performed at Genewiz's facility in...

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $12,823.88 on July 24, 2019. The order covers sequencing services at the awardee's location in Piscataway, New Jersey, with an ultimate completion date of August 23, 2019. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to GenScript USA Inc. for $6,126.56 on July 28, 2017, for sequencing services. Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of September 30, 2017.</p>

<p>The National Cancer Institute issued a $2,675 delivery order to Genewiz, LLC on August 31, 2019, under the NCI Genomic Characterization Centers IDIQ for genomic characterization services supporting the Center for Cancer Genomics.</p> <p>The NCI Genomic Characterization Centers IDIQ provides cancer genomics capabilities to the National Cancer Institute. Place of performance is South Plainfield, NJ. The order was firm fixed price with an ultimate completion date of August 30, 2020.</p>

The U.S. government awarded a $24,080 firm fixed-price purchase order to Genewiz, LLC for DNA sequencing services. The contract was executed on May 23, 2017, with an ultimate completion date of July 31, 2017, and is being performed in South Plainfield, New Jersey. This award to the genomic services contractor carries no set-aside designation and represents work directly supporting a civilian federal agency through its Midwest Area office. Genewiz, LLC, a global contract research organization and...